Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: A pilot study

BACKGROUND & OBJECTIVES: Bone marrow mononuclear cell therapy has emerged as one of the option for the treatment of Stroke. Several preclinical studies have shown that the treatment with mononuclear cell (MNCs) can reduce the infarct size and improve the functional outcome. We evaluated the feas...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad, Kameshwar, Mohanty, Sujata, Bhatia, Rohit, Srivastava, M.V.P., Garg, Ajay, Srivastava, Achal, Goyal, Vinay, Tripathi, Manjari, Kumar, Amit, Bal, Chandrashekar, Vij, Aarti, Mishra, Nalini Kant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461733/
https://www.ncbi.nlm.nih.gov/pubmed/22960888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461733/
https://www.ncbi.nlm.nih.gov/pubmed/22960888

Ejemplares similares